Search Login Register

beraprost Summary

Description: stable prostacyclin analog; structure given in first source

Also Known As: 4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate; TRK 100; TRK-100; beraprost sodium; 1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-, monosodium salt

Networked: 177 relevant articles (29 outcomes, 36 trials/studies) for this Bio-Agent

Key Diseases for which beraprost is Relevant

  1. Pulmonary Hypertension (Ayerza Syndrome) : 7 outcomes 1 study in 40 results
  2. Peripheral Arterial Disease : 3 outcomes 4 studies in 10 results
  3. Systemic Scleroderma (Systemic Sclerosis) : 3 outcomes 1 study in 4 results
  4. Intermittent Claudication : 2 outcomes 7 studies in 10 results
  5. Arteriosclerosis Obliterans : 2 outcomes 4 studies in 6 results
Show All >>

Drugs Related to beraprost

  1. Epoprostenol (Prostacyclin)
  2. Idiopathic pulmonary hypertension
  3. sildenafil (Viagra)
  4. beraprost
  5. Vasodilator Agents (Vasodilators)
  6. Dinoprostone (PGE2)
  7. Alprostadil (Muse)
  8. NAD (NADH)
  9. bosentan (Tracleer)
  10. GTP Phosphohydrolases (GTPases)
Show All >>

Therapies Related to beraprost

  1. Oral Administration
  2. Ligation
  3. Prostheses and Implants (Prosthesis)
  4. Lung Transplantation
  5. Isogeneic Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.